Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
35.48    1.24 (3.62%)
Bid:
35.44
Ask:
35.56
Spread: 0.12 (0.339%)
Market Cap: £567.33m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Half-Year Report

27 Feb 2026 07:00

RNS Number : 6058U
Hays PLC
27 February 2026
Β 

Β 

Β 

Hays plc

Half-Year Report

Β 

27 February 2026

Hays plc ('Hays' or the 'Company') today announces its half-year report for the six months ended 31 December 2025 ('Half-Year Report'), which is available at: http://www.rns-pdf.londonstockexchange.com/rns/6058U_1-2026-2-26.pdf

The Half-Year Report will also be available on the Hays website www.hays.com/investors and has been submitted in full unedited text to the Financial Conduct Authority's National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Dividend

The interim dividend proposed of 0.15 pence per share is calculated on a consistent basis with the FY25 final dividend, representing 3x FY25 pre-exceptional earnings cover, and applying our historic one-third/two-thirds interim/final split.

The interim dividend will be paid on 23 April 2026 to shareholders on the register on 13 March 2026. A Dividend Reinvestment Plan (DRIP) is provided by Equiniti Financial Services Limited. The DRIP enables the Company's shareholders to elect to have their cash dividend payments used to purchase the Company's shares. More information can be found at www.shareview.co.uk/info/drip. The deadline to elect to participate in the DRIP is 30 March 2026.

Conference call

James Hilton, Chief Financial Officer, will conduct an audio webcast presentation for investors and analysts at 9:00am UK time on Friday 27 February, details of which are provided below:

Registration for audio conference call, with ability to ask questions

https://register-conf.media-server.com/register/BIbff574b493dc491eb443260f86c58362

Registration URL for webcast only

https://edge.media-server.com/mmc/p/nugo8fzp

this link will give access to the audience to the live stream of the event, with slides and web Q&A function.

Once you register you will receive a confirmation email, with the details of the call and a personal login link and PIN which will place you directly into the call, without the need to speak to an operator. The call will be recorded and will also be available for playback via the results centre on our investor website.

Β 

Β 

Β 

Enquiries

Hays plc

Β James Hilton

Group Finance Director

+44 (0) 203 978 2520

Β Kean Marden

Head of Investor Relations & M&A

+44 (0) 333 010 7092

Β 

Β 

FGS Global

Β Guy Lamming

hays@fgsglobal.com

Β Richard Crowley

Β 

Β 

LEI: 213800QC8AWD4BO8TH08

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IR FLFSDFFIRFIR
Date   Source Headline
25th Sep 20253:54 pmRNSDirector/PDMR Shareholding
18th Sep 20251:29 pmRNSDirector/PDMR Shareholding
15th Sep 20254:50 pmRNSDirector/PDMR Shareholding
5th Sep 20252:52 pmRNSDirector/PDMR Shareholding
3rd Sep 20253:00 pmRNSDirector/PDMR Shareholding
1st Sep 202510:00 amRNSTotal Voting Rights
29th Aug 202512:59 pmRNSDirector/PDMR Shareholding
27th Aug 202512:32 pmRNSDirector/PDMR Shareholding
26th Aug 20253:43 pmRNSDirector/PDMR Shareholding
22nd Aug 20253:00 pmRNSDirector/PDMR Shareholding
21st Aug 20254:30 pmRNSDirector/PDMR Shareholding
21st Aug 20257:00 amRNSPreliminary Report 2025
4th Aug 20254:21 pmRNSTotal Voting Rights
1st Aug 202510:00 amRNSBlock listing Interim Review
23rd Jul 202510:38 amRNSHolding(s) in Company
14th Jul 20255:19 pmRNSHolding(s) in Company
11th Jul 20251:00 pmRNSAppointment of Joint Corporate Broker
4th Jul 20252:43 pmRNSBoard Committee membership changes
1st Jul 202510:00 amRNSTotal Voting Rights
24th Jun 20257:00 amRNSHolding(s) in Company
20th Jun 20259:37 amRNSDirector/PDMR Shareholding
19th Jun 202510:18 amRNSHolding(s) in Company
19th Jun 20257:00 amRNSPre-Close Year End Trading Update
4th Jun 20251:40 pmRNSHolding(s) in Company
3rd Jun 20255:54 pmRNSDirector/PDMR Shareholding
2nd Jun 202510:00 amRNSTotal Voting Rights
29th May 20253:46 pmRNSHolding(s) in Company
20th May 20254:55 pmRNSResponse to Voting Results at 2024 AGM
9th May 20252:24 pmRNSOutcome of Audit Tender Process
1st May 202510:00 amRNSTotal Voting Rights
16th Apr 20254:22 pmRNSDirector/PDMR Shareholding
16th Apr 20257:00 amRNSThird Quarter Trading Statement
15th Apr 20255:15 pmRNSDirector/PDMR Shareholding
10th Apr 20254:10 pmRNSDirector/PDMR Shareholding
1st Apr 202510:00 amRNSTotal Voting Rights
27th Mar 202512:05 pmRNSDirector/PDMR Shareholding
3rd Mar 202510:00 amRNSTotal Voting Rights
25th Feb 20252:30 pmRNSDirector/PDMR Shareholding
20th Feb 20257:00 amRNSHalf Year Report
3rd Feb 202510:15 amRNSBlock listing Interim Review
3rd Feb 202510:00 amRNSTotal Voting Rights
16th Jan 20257:00 amRNSBoard Changes
15th Jan 20257:00 amRNSSecond Quarter Trading Statement
13th Jan 20252:14 pmRNSDirector Declaration
2nd Jan 202510:50 amRNSHolding(s) in Company
2nd Jan 202510:35 amRNSTotal Voting Rights
17th Dec 20241:00 pmRNSDirector/PDMR Shareholding
16th Dec 20249:17 amRNSDirector/PDMR Shareholding
9th Dec 20242:37 pmRNSDB pension scheme de-risked with full buy-in
2nd Dec 202411:55 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.